EarGenie: Assessment of a Minimum Viable Product

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 14, 2023

Primary Completion Date

February 26, 2024

Study Completion Date

February 26, 2024

Conditions
Hearing Impaired Children
Interventions
DEVICE

EarGenie MVP test

The EarGenie test consists of placing the EarGenie headgear on the infant and running the fNIRS tests via the user interface. Blocks of speech sounds are presented to the infant via earphones or via speaker, and the EarGenie MVP measures changes in the blood oxygenation. Automatic analyses are run to determine whether the infant heard the sounds or discriminated between them. The infant will be in a natural sleep when the fNIRS test is run. Prior to the test, standard audiometric procedures (otoscopy and tympanometry) will confirm normal middle ear function.

Trial Locations (1)

3002

Bionics Institute, East Melbourne

All Listed Sponsors
lead

The Bionics Institute of Australia

OTHER

NCT05962814 - EarGenie: Assessment of a Minimum Viable Product | Biotech Hunter | Biotech Hunter